Company news

Sernova Biotherapeutics Inc news in 2025

Sernova Biotherapeutics Inc's news releases, calls and decks from 2025, newest first.

View company

Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts

November 13, 2025

Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang

October 1, 2025

Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors

September 23, 2025

Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference

September 8, 2025

Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

July 9, 2025

2025 Q2 MD&A

June 16, 2025

2025 Q2 Financial Statements

June 16, 2025

Sernova Appoints Jonathan Rigby as Interim Chair

June 2, 2025

Chair of Sernova Biotherapeutics Resigns

May 25, 2025

Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes

May 22, 2025

Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

May 14, 2025

Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

April 17, 2025

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

April 15, 2025

Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes

April 1, 2025

Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D

March 10, 2025

Sernova Biotherapeutics Secures $1 Million Convertible Debt Financing

March 5, 2025

Sernova Biotherapeutics Receives FDA Clearance for IND Application for its Cell Pouch Bio-hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism

March 3, 2025

Decks in 2025